Erratum: Zafarana G, Ishkanian AS, Malloff CA, Locke JA, Sykes J, Thoms J, Lam WL, Squire JA, Yoshimoto M, Ramnarine VR, Meng A, Ahmed O, Jurisca I, Milosevic M, Pintilie M, van der Kwast T and Bristow RG. Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer. 2012;118:4053‐62.

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|15|2380-2380

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.15, 2014-08, pp. : 2380-2380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erratum: TruongM, SlezakJA, LinCP, IremashviliV, SadoM, RazmariaAA, LeversonG, SolowayMS, EggenerSE, AbelEJ, DownsTM, and JarrardDF. Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer. 2013;119:3992–4002.

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 769-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of T1C, N3, M1 Prostate Cancer

By  

Urologia Internationalis, Vol. 69, Iss. 1, 2002-07 ,pp. : 82-84

Karger

Access to resources Recommend Favorite

C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 556-563

Karger

Access to resources Recommend Favorite

The Good, the Bad, and the T.M.J.

By Orthlieb Jean-Daniel  

Journal of Dentofacial Anomalies and Orthodontics, Vol. 14, Iss. 2, 2011-09 ,pp. : 201-201

Edp Sciences

Access to resources Recommend Favorite

Brief Gene Mapping Reports A / B / C / D / E / F / G / H / I / J / K / L / M

By  

Cytogenetic and Genome Research, Vol. 112, Iss. 3-4, 2006-02 ,pp. : 341-342

Karger

Access to resources Recommend Favorite